Physicochemical Properties
| Molecular Formula | C24H23NO2 |
| Molecular Weight | 357.44492650032 |
| Exact Mass | 357.172 |
| CAS # | 1141802-49-4 |
| PubChem CID | 44572264 |
| Appearance | Typically exists as solid at room temperature |
| LogP | 6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 5 |
| Heavy Atom Count | 27 |
| Complexity | 435 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | YNYOWRRXJIPCGX-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C24H23NO2/c26-24(25-22-13-7-8-14-22)27-23-16-20(18-9-3-1-4-10-18)15-21(17-23)19-11-5-2-6-12-19/h1-6,9-12,15-17,22H,7-8,13-14H2,(H,25,26) |
| Chemical Name | (3,5-diphenylphenyl) N-cyclopentylcarbamate |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | recLH and Org 43553[1] |
| ln Vitro | Concentration-dependent allosteric inhibition is observed with LUF5771 (1 µM or 10 µM). LUF5771 causes radioligand dissociation to rise noticeably. Like Org 43553, LUF5771 most likely binds to the seven transmembrane domain. The LH receptor can be partially activated by 31 ±4% with just 10 µM of LUF5771[1]. |
| References | [1]. Laura H. Heitman, et al. Substituted Terphenyl Compounds as the First Class of Low Molecular Weight Allosteric Inhibitors of the Luteinizing Hormone Receptor. Journal of Medicinal Chemistry 2009 52 (7), 2036-2042 |
Solubility Data
| Solubility (In Vitro) | DMSO: 100 mg/mL (279.77 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (6.99 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.7977 mL | 13.9884 mL | 27.9767 mL | |
| 5 mM | 0.5595 mL | 2.7977 mL | 5.5953 mL | |
| 10 mM | 0.2798 mL | 1.3988 mL | 2.7977 mL |